{
  "docId": "019de075-5029-738c-8512-9456f77efe7c",
  "docSlug": "25c628cfc0779f52594519f9e322dc70",
  "documentTitle": "Genelux | Investor Presentation Deck | 38 slides",
  "authorId": "genelux",
  "authorName": "Genelux",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 38,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "Includes a spider plot (tumor shrinkage over time) and a waterfall plot (duration of response).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-5029-738c-8512-9456f77efe7c/14",
  "deckHref": "/decks/019de075-5029-738c-8512-9456f77efe7c",
  "deckJsonHref": "/decks/019de075-5029-738c-8512-9456f77efe7c.json",
  "deckAnchorHref": "/decks/019de075-5029-738c-8512-9456f77efe7c#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.28,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "callout",
      "text": "Key Clinical Takeaways",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e107084f-74b3-461b-bc98-c97d42f77a08",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.6,
        "x": 0.35,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Duration of Response",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bdcae63d-c054-4b21-96e6-787ddefab46b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.6,
        "x": 0.35,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Tumor Shrinkage",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "954a48dd-b12b-4e65-8104-829c69981922",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.28,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "list",
      "text": "Overall, 86% of PRROC patients showed tumor reduction, with 91% of Platinum-refractory patients showing tumor reduction. Four patients had 100% reduction. DOR of 7.6 Months in all platinum-Resistant patients. DOR of 8.0 Months in platinum-refractory patients.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "458dc318-bf70-4342-a939-7966b00a7a9c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Demonstrated Deep and Durable Tumor Shrinkage",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e463d47e-59e6-4f01-b9d4-ddd8092f9281",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "439e07d1-6eaa-4e4b-945f-41e93f76bc82",
      "evidence": "list/bullet: Overall, 86% of PRROC patients showed tumor reduction, with 91% of Platinum-refractory patients showing tumor reduction.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "data-story-arc",
      "slug": null,
      "matchId": "6e837a60-60d7-4a22-a50e-684396b8a553",
      "evidence": "Presents clinical data to support a specific therapeutic efficacy claim.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 15,
      "from": 12,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "111fab6b-cd67-49dd-a414-d1390f2ab5d3",
      "evidence": "The presentation presents data on the clinical reversal of platinum resistance and refractoriness among patients with PRROC, highlighting the potential benefits of using Olvi-Vec.",
      "position": 0,
      "objective": "To highlight the cost of not using Olvi-Vec, specifically the limited treatment options for patients with platinum-resistant or platinum-refractory ovarian cancer",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}